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Background: An influenza H3N2 epidemic occurred throughout Southern China in 2012.
Methods: We analyzed the hemagglutinin (HA) and neuraminidase (NA) genes of influenza H3N2 strains isolated
between 2011–2012 from Guangdong. Mutation sites, evolutionary selection, antigenic sites, and N-glycosylation
within these strains were analyzed.
Results: The 2011–2012 Guangdong strains contained the HA-A214S, HA-V239I, HA-N328S, NA-L81P, and NA-D93G
mutations, similar to those seen in the A/ Perth/16/2009 influenza strain. The HA-NSS061–063 and NNS160–162
glycosylation sites were prevalent among the 2011–2012 Guangdong strains but the NA-NRS402–404 site was
deleted. Antigenically, there was a four-fold difference between A/Perth/16/2009 -like strains and the 2011–2012
Guangdong strains.
Conclusion: Antigenic drift of the H3N2 subtype contributed to the occurrence of the Southern China influenza
epidemic of 2012.
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Influenza virus undergoes rapid evolution by both anti-
genic shift and antigenic drift and this presents a signifi-
cant challenge for vaccine design to best match with
viruses likely to circulate in the coming influenza season
[1,2]. Since their emergence in 1968, influenza H3N2 vi-
ruses tend to be highly prevalent most years. The two
dominant proteins in this particular virus strains are the
H3 hemagglutinin (HA) and N2 neuraminidase (NA)
surface glycoproteins [1,3]. Antigenic drift, also known
as the result of positive selection, generally involves both
of these proteins, resulting in evasion of the host im-
mune response [4]. Many amino acid variations occur at
the antibody binding sites, creating diversity in the HA
and NA proteins and allowing them to evade host anti-
bodies. However, these variations do not significantly* Correspondence: pphuang1@163.com
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reproduction in any medium, provided the oralter the stereochemical or functional properties of HA
and NA.
In Canada, antigenic drift was observed in 2008 when
the A/Brisbane/10/2007 strain (the vaccine strain used
in 2008–2009 and 2009–2010) mutated into the A/Perth/
16/2009 strain (vaccine strain used in 2010–2011) [5].
Antigenic and molecular characterization of H3N2 vi-
ruses over those three seasons revealed that the number
of HA mutations is important, along with the nature
and location of key mutations, and likely plays a signifi-
cant role in antigenic drift. In previous work, amino
acid substitutions were seen in five antigenic regions of
HA1 from 2007–2011 Guangdong (for short GD) iso-
lates; in particular, regions B (N160K) and D (K174R/
N). The K189E/N/Q and T228A mutations within the
receptor-binding site (RBS) were present in the 2010
strains, affecting the antigenicity of HA1 [6]. The anti-
genicity of epidemic H3N2 isolates in 2011 differed
from that of the A/Perth/16/2009 strain.
The evolution and epidemiology of influenza H3N2
viruses is partially related to global migration dynamics
[7]. The evolution of H3N2 influenza over the pastLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Zhong et al. Virology Journal 2013, 10:345 Page 2 of 7
http://www.virologyj.com/content/10/1/34510 years reflects the dynamics of a global metapopula-
tion. According to the Center for Public Health Surveil-
lance and Information Service of China [8], the number
of influenza cases was 2.35-fold greater for January–
June 2012 (74,151 cases) than for January–June 2011
(31,551 cases). Approximately 87% (365/418) of isolates
were of the H3N2 subtype; these isolates were sourced
from local epidemics and sporadic cases reported in
Guangdong Province from March–June 2012. We ana-
lyzed HA and NA gene sequences of H3N2 viruses iso-
lated from July 2011 to July 2012.
Materials and methods
Viruses and genes
With assistance from the Guangdong Influenza Surveil-
lance Network, H3N2 viruses from 2011–2012 were iso-
lated in MDCK cell lines [6]. Viruses investigated in our
study included four 2011 and four 2012 isolates (GenBank
Accession Nos. CY125677–CY125692). Isolates from
Zhuhai, Shaoguan, Foshan, Maoming and Meizhou are
presented in Figure 1 and Table 1. Around 60 HA and 55
NA gene sequences were downloaded from the Influenza
Virus Resource (http://www.ncbi.nlm.nih.gov/genomes/
FLU/Database/nph-select.cgi?go=alignment), and included
vaccine strains A/Wyoing/03/2003, A/California/ 07/2004,
A/Wisconsin/05/2005, A/Brisbane/07 /2007 and A/Perth/
16/2009 as references. In reference 60 HA genes and 55
NA genes, both 44 HA and NA genes viruses were iso-
lated from Asia, Europe, North America, South America
and Oceania from 1968 to 2011 while 16 HA genes from
Asia (4 genes from Japan and Russia Asia region), Europe
(8 genes from Russia and George) and North America (4Figure 1 Strains sampled from different cities in Guangdong. Stains w
Shaoguan, three separately from Foshan, Maoming and Meizhou.genes from USA) and 9 NA genes from Asia (2 genes
from Russia Asia region) and Europe (7 genes from
Russia and George) isolated in 2012.
Molecular detection of viral genes
Primers specific for the HA and NA genes of human
H3N2 isolated from 1968–2010 were designed using
Primer Premier 5.0 (Premier Biosoft International, Palo
Alto, CA, USA) and synthesized by Life Technologies
(Shanghai, China). These primers have been used in a pre-
vious study [6]. Viral RNA was extracted using a Qiagen
QIAamp Viral RNA mini Kit, and reverse transcription
polymerase chain reactions (RT-PCRs) conducted with
Qiagen Sensiscript Reverse Transcriptase and Takara Pyr-
oBest Taq. Amplicons were purified with a Qiagen Gel Ex-
traction Kit and sequenced with an ABI PRISM BigDye
Terminator v3.0 Ready Reaction Cycle Sequence Kit on
an ABI PRISM 3100 Genetic Analyzer. The obtained se-
quences were analyzed using Lasergene 7.1.
Phylogenetic analysis and evolutionary dynamics
Virus population dynamics over time were estimated
using the BEAST package v1.70 [9] and applying Bayesian
Markov chain Monte Carlo (MCMC) methods. Phylogen-
etic trees were generated, and the reliability of trees tested
by bootstrap analysis using 1000 replicates. The MCMC
analysis was run for 50,000,000 generations, with station-
arity and mixing efficiency examined using Tracer.
Evolutionary selection and N-glycosylation
Single likelihood ancestor counting (SLAC) was appro-
priate for large alignments but possibly underestimatesere isolated from the samples included three from Zhuhai, two from
Table 1 Influenza A H3N2 viruses used in this study




Cell line isolated in GenBank sequence accession no.
HA NA
A/Guangdong/174/2011 8/16/2011 Zhuhai MDCK2 CY125683 CY125684
A/Guangdong/187/2011 9/26/2011 Zhuhai MDCK2 CY125685 CY125686
A/Guangdong/192/2011 9/15/2011 Dongguan MDCK2 CY125687 CY125688
A/Guangdong/222/2011 11/23/2011 Shaoguan MDCK1 CY125689 CY125690
A/Guangdong/947/2012 3/27/2012 Meizhou MDCK1 CY125691 CY125692
A/Guangdong/1078/2012 4/9/2012 Maoming MDCK1 CY125677 CY125678
A/Guangdong/1104/2012 3/29/2012 Zhuhai MDCK1 CY125679 CY125680
A/Guangdong/1154/2012 4/25/2012 Shaoguan MDCK2 CY125681 CY125682
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effects likelihood (FEL) and the internal fixed-effects likeli-
hood (IFEL) took the synonymous and non-synonymous
substitutions into account and could be efficiently paralle-
lized. Potential N-glycosylation sites were predicted using
NetNGlyc 1.0 server [11]. This software application pre-
dicts N-glycosylation sites in human proteins using
artificial neural networks that examine the N-X-S/T
(Asn-Xaa-Ser/Thr) amino acid sequence [12].
Antigenic analysis, epitope region and three-dimensional
(3D) structure
Cross-reactivity of isolated viruses was investigated using
hemagglutination inhibition (HI) assays [13]. The vari-
ation sites in H3N2 virus HA and NA gene sequences
isolated from 2011 and 2012 were compared with previ-
ously identified epitopes of HA and NA proteins [14].
The 3D structures of HA and NA proteins were estab-
lished using the I-TASSER server [15]. Models were
modified with UCSF Chimera1.5.3 [16].
Results
Phylogenic diversity and variation
Using five vaccine strains as a reference, amino acid substi-
tution sites in HA genes of Guangdong strains and other
strains isolated from 2007–2012 became apparent. These
substitutions included K174R in the 2008 Guangdong
strains, along with E78K and N160K in A/Perth/16/2009
and the 2009 Guangdong strains. Since 2009, two groups
of strains have emerged. The first group includes strains
A/GD/441/2010, A/GD/94/2011, and A/California/3000/
2012; these contain the HA-D69N, HA-Y110H, HA-I246V
and HA-E296A/T substitutions. The second group in-
cludes strains A/GD/222/2011, A/GD/187/2011, A/GD/
1154, and A/GD/222/2011; these strains contain the
HA-A214S, HA-V239I and HA- N328S substitutions
(Figure 2a). In two 2011 Guangdong strains (A/GD/94/
2011 and A/GD/174/2011) we observed G21E and E296T
substitutions in HA, while two USA 2012 strains alsocontained the E296T substitution. For the Guangdong
strain group containing the HA-A214S, V239I and N328S
substitutions, we also noticed Q49R and S61N substitu-
tions in A/GD/222/2011 and A/GD/1154/2012; while A/
GD/187/2011 and Russian strains from 2012 only con-
tained D503N.
Using the five vaccine strains as a reference, amino
acid substitution sites in the NA genes of Guangdong
and other strains isolated from 2007–2012 were appar-
ent (Figure 2b). Since 2009, variation sites in strains
from around the world have been seen: L81P for 2011
Guangdong isolates, and Russian and Georgian isolates
from 2012; D93G for A/GD/222/2011, and Russian and
Guangdong isolates from 2012; S367N and K369T for
Guangdong isolates from 2010–2012, Danish isolates from
2011, and Russian and Georgian isolates from 2012;
N402D for 2011–2012 Guangdong isolates, Japanese and
Swedish isolates from 2010, and Russian and Georgian
isolates from 2012. In addition, the K249E substitution oc-
curred in four 2007 Guangdong strains, G401D was seen
in three 2008 Guangdong strains, and D127N was found
in A/GD/472/2009 and three other strains.
Evolutionary selection and N-glycosylation
Only codon 173 (L/S) of the 566 codons in the HA gene
was a positively selected site with a dN-dS of 3.08, and a
P-value of 0.0944 for SLAC. Codons 237 (P/S/T/L) and
239 (V/I) were positively selected sites with dN-dS of
7.56 × 108 and 6.96 × 108, respectively, and P-values of
0.0318 and 0.0794, respectively for FEL. Codons 174 (K/
N/R/G) and 209 (S/F) were positively selected sites with
normalized dN-dS of 16.7 and 18.6 respectively, and P-
values of 0.0502 and 0.0315 respectively for IFEL.
Codon 338 (L/R/F), of the 469 codons for NA was a
positively selected site with a dN-dS of 9.39 × 108 and a
P-value of 0.0498 for FEL. Codons 338 and 372 (S/L/F)
were positively selected sites with dN-dS of 1.15 × 109
and 1.23 × 109 respectively and P-values of 0.0828 and
0.0887 respectively for IFEL.
Figure 2 Phylogenetic analysis of influenza H3N2 HA and NA genes applied MCMC. a. HA; b. NA. The strains shared the same mutation
sites clustered into one clad in the same color, where Guangdong strains were in red.
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HA gene of the A/GD/1154/2012 isolate: NST024–026,
NGT038–040, NAT054–056, NSS061–063, NCT079–081,
NES138–140, NWT142–144, NGT149–151, NNS160–162,
NVT181–183, NST262–264, NGS301–303 and NGT499–501. For
the A/Perth/16/2009 HA gene, 11 potential glycosylationsites were present, with only NSS061–063 and NNS160–162
missing. Using the A/Perth/16/2009 HA gene as a
reference, S61N was seen in 2011–2012 Guangdong and
other strains, resulting in a gain of the NSS061–063 glyco-
sylation site. The N161S substitution occurred in the
2011–2012 Guangdong strains, resulting in an increase of
Table 3 Sites of variation associated with antigenic
epitopess
Gene Position Mutation Epitope ID*
HA 69 D→ N 129460, 130279, 128706
HA 110 Y→ H 128649, 128428, 129924
HA 246 I→ V 129617, 97393, 129652,
97243, 129656
HA 296 E→ A/T 129824, 128724
HA 214 A→ S 130111, 129953
HA 239 V→ I 129617, 97393, 129652
HA 328 N→ S 129763, 129381. 129136
NA 81 L→ P 130081, 128380
NA 93 D→ G 130400, 129643
*The reference B cell epitopes/ T cell epitopes of H3N2 strain was from
A/New York/384/2005.
Zhong et al. Virology Journal 2013, 10:345 Page 5 of 7
http://www.virologyj.com/content/10/1/345the NNS160–162 glycosylation sites. The S140C substitution
occurred in A/Tbilisi/GNCDC0557/2012, resulting in de-
letion of the NES138–140 glycosylation site.
There were eight potential glycosylation sites in the
NA gene of the A/GD/1154/2012 isolate: NIT61–63,
NTT70–72, NWS86–88, NDT146–148, NAT200–202, NGT234–
236, NDS329–331, and NRS402–404. The N402D substitu-
tion occurred in the 2011–2012 Guangdong isolates, the
2010 Japanese and Swedish isolates, and the 2012 Rus-
sian and Georgian isolates. This resulted in deletion of
the NRS402–404 glycosylation site.
Antigenic analysis, epitope and 3-D structure
Hemagglutination inhibition assays were conducted using
antisera from rabbits infected with Guangdong H3N2 vi-
ruses isolated from 2009–2012. When compared with A/
GD/1105/2009, strain A/GD/1154/2012 exhibited a 4-fold
difference in titers (Table 2). Each mutation site in HA
(D69N, Y110H, I246V, E296A/T, A214S, V239I and N328S)
involved the epitope regions of A/New York/384/2005
(Table 3). The 3D structures of HA and NA proteins for A/
GD/1154/2012 were modeled; HA (Q49R, A214S, V239I,
N328S and D503N) and NA (L81P, D/N93G, S367N,
K369N and N402D) variation sites were labeled in the 3D
structures (Figure 3).
Discussion
Mutated amino acids around human leukocyte antigen
(HLA)-associated sites, especially those that are typically
conserved, suggest that cooperative interactions act to
preserve the local structural stability and protein func-
tion when mutations occur that confer evasion of cyto-
toxic T lymphocytes (CTLs) [17]. For the HA genes of
isolated strains, the D69N, Y110H, I246V and E296A/T
substitutions occurred around 2010 [6], while A214S,
V239I and N328S have been present since 2011. Accu-
mulation of HA (D69N, Y110H, I246V, E296A/T, A214S,
V239I and N328S), along with NA (L81P and D93G)
mutations, drove antigenic drift possibly giving rise to
the H3N2 influenza epidemic in Guangdong and South-
ern China in 2012. The HA-A214S, -V239I and -N328S
mutations occurred in the second half of 2011 (Table 1
and Figure 2). As the 2012 influenza season approached,Table 2 Hemagglutination inhibition results for the H3N2
strains examined in this study







A/GD/1105/2009 1:2560 1:640 1:640
A/GD/222/2011 1:1280 1:1280 1:1280
A/GD/1154/2012 1:640 1:640 1:1280
GD, Guangdong.
Strain A/GD/1105/2009 is a vaccine strain.these variations in circulating strains became prevalent,
resulting in local epidemics throughout Southern China.
According to a previous study that focused on isolates
from 2011 [18], HA1 genes were sub-divided among the
P (A/Perth/16/2009-Clade) and V (A/Victoria/208/2009-
Clade) clades. The former included subgroups1 and 2,
while the latter included subgroups 3–6. When we com-
pared our findings with the results from Klimov [18] and
Huang [6], mutations A/N144T/D and K/N145N/S were
only observed in the previous studies; the mutations we
have reported here were not evident in Klimov’s work.
The mutations in the 2012 Guangdong isolates appear to
have given rise to antigenic drift. Generally, five HA1 anti-
genic regions are analyzed and associated with antigenic
drift that results in an epidemic. However, for the particu-
lar epidemic we investigated, these five regions were not
seemingly associated with antigenic drift. Only the A214S
substitution occurred in epitope D and the RBS. Beside
the five HA1 antigenic regions, many amino acid sites
were unclassified but still considered important [6]. Using
the H3N2 HA and NA protein sequences of A/New York/
348/ 2005 as a reference, all mutated amino acid sites
were related to previously identified epitopes, which might
involve in antigenic presentation / recognition / response.
This indicated that mutations of B cell epitope / T cell epi-
tope regions in the Immune Database influenced antige-
nicity to some degree [14]. These B cell epitopes / T cell
epitopes span 17–18 amino acids in the A/New York/348/
2005 strain. Further research is required to confirm the re-
lationship between antigenicity and mutations in HA and
NA genes.
As was observed for of major capsid L1 protein of HPV-
16 and −18, amino acids at positions 174 (K/N/R/G), 209
(S/F), 237 (P/S/T/L) and 239 (V/I) in HA, and at positions
338 (L/R/F) and 372 (S/L/F) in NA were positively se-
lected sites according to SLAC, FEL and IFEL (P < 0.1),
Figure 3 Mutation sites on HA and NA proteins of H3N2 viruses isolated during 2011-2012. The 3D structures were modeled from strain
A/Guangdong/1154/2012, where the red balls were the mutation sites.
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for their continued persistence [19].
Only 76% of positive scored sequons according to NetN-
Glyc are modified by N-Glycans with a bias towards Thr-
containing sequons [20]. Compared with A/Perth/16/2009,
two glycosylation sites (NSS061–063 and NNS160–162) in HA
genes were prevalent in 2011–2012 Guangdong strains,
with the NA glycosylation site N402D deleted. There are
five possible functions for glycosite migration in human in-
fluenza viruses [21]: to more effectively mask the antigenic
sites; to more effectively protect enzymatic cleavage sites of
NA; to stabilize polymeric structures; to regulate receptor
binding and catalytic activities; and to balance the binding
activity of HA with the release activity of NA. Five HA gly-
cosites and two NA glycosites were positive sites in this
study. Gains in N-glycosylation sites were likely to be posi-
tively selected for shielding antigenic sites from immune
responses [22]. The acquisition of glycosylation at residues
144 of pH1N1 was associated with viral replication, viru-
lence and transmissibility and provided insights into theevolution dynamics of influenza viruses with implications
in vaccine immunogenicity [23]. The loss of a glycosylation
site might also be important in antibody recognition [22],
where a deletion of the NA-NRS402–404 occurred in the
2011–2012 Guangdong and other isolates in this study.
With respect to HA/NA N-glycosylation changing, further
analysis is required to determine any relationship between
their structure mutation and function influence. At the
antigenic sites of HA protein, positive selection appeared
to have effected radical and conservation substitution in
term of the charge of the amino acids, suggesting that
antigenic drift is not a byproduct of HA evolution in H3N2
viruses [22].
Kenyan H3N2 viruses isolated during 2006–2007 re-
vealed unique genetic variations, with several amino acid
substitutions located at immunodominant epitopes of
the HA1 protein [24]. These mutations included V112I
at site E, K173 E at site D and N278K at site C. These
mutations possibly result in a conformational change to
the HA molecule, thereby exposing novel epitopes and
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these sites. A Canadian study in 2011 involving antigenic
and molecular characterization of H3N2 viruses over
three seasons revealed that the number of HA mutations
was important, along with the nature and location of key
mutations, and played a significant role in antigenic drift
[5]. From our findings, presented in this report, the 2012
strains had evolved genetically and antigenically from
the A/Perth/16/2009 vaccine-like strains. The A/GD/
1154/2012 strain was antigenically distinct from the A/
GD/1105/2009 strain, suggesting that it may be the
parental strain responsible for the 2012 H3N2 influenza
virus epidemics in Southern China. Although influenza
H3N2 viruses varied genetically and antigenically during
2009–2011 [6], we concluded that antigenic drift in 2012
along with the accumulation of evolutionary mutations
in viruses isolated in 2012 played an important role in
the influenza epidemics of Guangdong and Southern
China during that period.
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